Christopher is a health economist and Principal Investigator on PACEOMICS. His primary research interest is in the development of efficient research and development processes for biotherapies and devices in the context of value based reimbursement market access hurdles.  He has published over 100 hundred peer-reviewed papers, book chapters and monographs.

He holds a Capital Health Endowed Research Chair at the University of Alberta, having previously held Chairs at the Universities of Leeds, Warwick and Sheffield. He continues to hold a Visiting Chair at the University of Leeds. He has acted as a consultant for public and private sector organizations in Europe, North America and Australasia; most notably with NICE in the United Kingdom, with whom he had various roles between 2003 and 2011.